test

Derek Gould

@Logos Global Management Lp

Latest period2024 - Q3ReportedManaged Assets$926.849MTotal holdings55
Assets growth rate-62.55%Assets growth rate (2-Q avg)18.89%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Logos Global Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 55 positions.

Assets under management

The assets under management (AUM) of Logos Global Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 926.849M in assets, with a quarterly growth rate of -62.55% and a 2-quarter average growth rate of 18.89%. The portfolio is managed by Derek Gould, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TRVITrevi Therapeutics Inc
Recent Activity
Decreased -50.89%
1%
$9.185M
2.75M shares@ $3.34 avg price
NUVLNuvalent Inc
Recent Activity
Decreased -80.76%
0.83%
$7.673M
75,000 shares@ $102.3 avg price
CMPSCompass Pathways Plc
Recent Activity
Decreased -50%
0.79%
$7.302M
1.159M shares@ $6.3 avg price
ORKAOruka Therapeutics Inc
Recent Activity
New Position
0.69%
$6.307M
257,330 shares@ $24.51 avg price
RCKTRocket Pharmaceuticals Inc
Recent Activity
Decreased -53.57%
0.65%
$6.003M
325,000 shares@ $18.47 avg price
SYRESpyre Therapeutics Inc
Recent Activity
Decreased -82.6%
0.64%
$5.882M
200,000 shares@ $29.41 avg price
DYNDyne Therapeutics Inc
Recent Activity
Decreased -69.81%
0.63%
$5.747M
160,000 shares@ $35.92 avg price
ATXSAstria Therapeutics Inc
Recent Activity
Decreased -50%
0.6%
$5.505M
500,000 shares@ $11.01 avg price
FULCFulcrum Therapeutics Inc
Recent Activity
Decreased -50%
0.58%
$5.355M↑ Call
1.5M shares@ $3.57 avg price
CYBNCybin Inc
Recent Activity
New Position
0.58%
$5.334M
600,000 shares@ $8.89 avg price